Literatur
- 1
Albrecht S, Zimmermann T, Freidt M, Freidt T, Saeger H D, Distler W.
Interaction
of N0, endothelin and oxalate in patients with systemic inflammatory
response syndrome (S.I.R.S.).
Biomed Chromatograph.
1997;
11/2
77-78
- 2
Albrecht S, Zimmermann T, Grützmann R, Scheller D, Saeger H D, Distler W.
Zum
redoxsensitiven Verhalten von Selenit in Gegenwart reaktiver Sauerstoffspezies.
Med Klinik.
1999;
94 Suppl.
III
70-73
- 3
Albrecht S, Zimmermann T, Ockert D.
Verhindert Selen die Peroxynitritbildung aus NO bei gefäßchirurgischen
Eingriffen?.
Med Klinik.
1997;
92
Suppl. III
10-71
- 4
Arteel G E, Briviba K, Sies H.
Protection against peroxynitrite.
FEBS Lett.
1999;
445
226-230
- 5
Arteel G E, Mostert V, Oubrahim H.
Protection by selenoprotein P in human plasma against peroxynitrite-mediated
oxidation and nitration.
Biol Chem.
1998;
379
1201-1205
- 6
Beckman J S, Koppenol W H.
Nitric oxide,
superoxide, and peroxynitrite: the good, the bad, and ugly.
Am
J Physiol.
1996;
271
C1424-1437
- 7
Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C,
Baeuerle P A, Neumeier D.
Activated transcription
factor nuclear factor-kappa B is present in the atherosclerotic
lesion.
J Clin Invest.
1996;
97
1715-1722
- 8
Cannon R O.
Role of nitric oxide in cardiovascular disease: focus on the
endothelium.
Clin Chem.
1998;
44
1809-1819
- 9
Carr A C, McCall M R, Frei B.
Oxidation of LDL by myeloperoxidase and reactive nitrogen species:
reaction pathways and antioxidant protection.
Arterioscler
Thromb Vasc Biol.
2000;
20
1716-1723
- 10
Darley-Usmar V, Halliwell B.
”Blood radicals:
reactive nitrogen species, reactive oxygen species, transition metal
ions, and the vascular system.
Pharm Res.
1996;
13
649-662
- 11
Dickhout J G, Hossain G S, Pozza L M, Zhou J, Lhoták S, Austin R C.
Peroxynitrite
causes endoplasmic reticulum stress and apoptosis in human vascular
endothelium: implications in atherogenesis.
Arterioscler
Thromb Vasc Biol.
2005;
25
2623-2629
- 12
Dusting G J, Fennessy P, Yin Z L, Gurevich V.
Nitric oxide in atherosclerosis:
vascular protector or villain?.
Clin Exp Pharmacol Physiol.
1998;
Suppl. Nov
34-41
- 13
Hogg N, Kalyanaraman B.
Nitric oxide and
lipid peroxidation.
Biochim Biophys Acta.
1999;
1411
378-384
- 14
Huie R E, Padmaja S.
The reaction of no with
superoxide.
Free Radic Res Comm.
1993;
18
195-199
- 15
Kersting S, Zimmermann T, von Gagern G, Ratayczak D, Albrecht S, Ockert D, Saeger H D.
Regulation of the ischemia reperfusion syndrome in liver ischemia
by transcription factors – a clinical trial using chemiluminometreic
methods.
Luminescence.
2002;
17
193-195
- 16
Luther B, Lehmann C, Grune T, Meyer R, Schwenke G, Beutel H, Bürger K.
Controlled reperfusion of ischemic extremity musculature to
prevent free radical induced lesions.
Zentralbl Chir.
1999;
124
336-343
- 17
Maytin M, Leopold J, Loscalzo J.
Oxidant stress in the vasculature.
Curr Atheroscler
Rep.
1999;
21
156-164
- 18
Münzel T, Heitzer T, Harrison D G.
The physiology and pathophysiology of the nitric oxide/superoxide
system.
Herz.
1997;
22
158-172
- 19
Schellong S M, Ockert D, Zimmermann T.
Pathophysiologie und Klinik des Ischämie-Reperfusions-Schadens
an der Skelettmuskulatur.
Vasa.
1998;
27
207-215
- 20 Zimmermann T, Albrecht S, Nagel M, Trausch M, Benusch T. Measurements of ATP in
blood plasma samples in cases of surgery – a
comparison to lipid peroxidation state, CL response of leukocytes
and oxidative potential. Bioluminescence and Chemiluminescence Fundamentals
and Applied Aspects. eds. A.K. Campbell, L. Kricka, P. Stanley 1995: 470-473 ISBN
0-471-95548-5
- 21
Zimmermann T, Albrecht S, Scheller D, Grützmann R.
Redoxsensitive characteristics
of selenite in presence of reactive oxygen species – are
there any nonenzymatic direct reactions?.
Luminescence.
2000;
15
118-119
Priv.-Doz. Dr. med. Thomas Zimmermann
Klinikum Spandau, Klinik für Chirurgie-Visceral-
und Gefäßchirurgie, Zentrum für Minimal-Invasive
Chirurgie
Neue Bergstraße 6
13585 Berlin
Email: Thomas.Zimmermann@vivantes.de
